Literature DB >> 21193540

Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans.

Joshua J Gooley1, Kyle Chamberlain, Kurt A Smith, Sat Bir S Khalsa, Shantha M W Rajaratnam, Eliza Van Reen, Jamie M Zeitzer, Charles A Czeisler, Steven W Lockley.   

Abstract

CONTEXT: Millions of individuals habitually expose themselves to room light in the hours before bedtime, yet the effects of this behavior on melatonin signaling are not well recognized.
OBJECTIVE: We tested the hypothesis that exposure to room light in the late evening suppresses the onset of melatonin synthesis and shortens the duration of melatonin production.
DESIGN: In a retrospective analysis, we compared daily melatonin profiles in individuals living in room light (<200 lux) vs. dim light (<3 lux). PATIENTS: Healthy volunteers (n = 116, 18-30 yr) were recruited from the general population to participate in one of two studies.
SETTING: Participants lived in a General Clinical Research Center for at least five consecutive days. INTERVENTION: Individuals were exposed to room light or dim light in the 8 h preceding bedtime. OUTCOME MEASURES: Melatonin duration, onset and offset, suppression, and phase angle of entrainment were determined.
RESULTS: Compared with dim light, exposure to room light before bedtime suppressed melatonin, resulting in a later melatonin onset in 99.0% of individuals and shortening melatonin duration by about 90 min. Also, exposure to room light during the usual hours of sleep suppressed melatonin by greater than 50% in most (85%) trials.
CONCLUSIONS: These findings indicate that room light exerts a profound suppressive effect on melatonin levels and shortens the body's internal representation of night duration. Hence, chronically exposing oneself to electrical lighting in the late evening disrupts melatonin signaling and could therefore potentially impact sleep, thermoregulation, blood pressure, and glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193540      PMCID: PMC3047226          DOI: 10.1210/jc.2010-2098

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

Review 1.  Clinical uses of melatonin: evaluation of human trials.

Authors:  E J Sánchez-Barceló; M D Mediavilla; D X Tan; R J Reiter
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

2.  Total visual blindness is protective against breast cancer.

Authors:  Erin E Flynn-Evans; Richard G Stevens; Homayoun Tabandeh; Eva S Schernhammer; Steven W Lockley
Journal:  Cancer Causes Control       Date:  2009-08-01       Impact factor: 2.506

3.  Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light.

Authors:  Joshua J Gooley; Shantha M W Rajaratnam; George C Brainard; Richard E Kronauer; Charles A Czeisler; Steven W Lockley
Journal:  Sci Transl Med       Date:  2010-05-12       Impact factor: 17.956

4.  Melatonin administration can entrain the free-running circadian system of blind subjects.

Authors:  S W Lockley; D J Skene; K James; K Thapan; J Wright; J Arendt
Journal:  J Endocrinol       Date:  2000-01       Impact factor: 4.286

5.  Removal of melatonin receptor type 1 induces insulin resistance in the mouse.

Authors:  Susana Contreras-Alcantara; Kenkichi Baba; Gianluca Tosini
Journal:  Obesity (Silver Spring)       Date:  2010-02-18       Impact factor: 5.002

Review 6.  Effects of poor and short sleep on glucose metabolism and obesity risk.

Authors:  Karine Spiegel; Esra Tasali; Rachel Leproult; Eve Van Cauter
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

7.  Light-at-night, circadian disruption and breast cancer: assessment of existing evidence.

Authors:  Richard G Stevens
Journal:  Int J Epidemiol       Date:  2009-04-20       Impact factor: 7.196

8.  Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose.

Authors:  Eckhard Mühlbauer; Elena Gross; Karin Labucay; Sabine Wolgast; Elmar Peschke
Journal:  Eur J Pharmacol       Date:  2009-01-29       Impact factor: 4.432

9.  Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.

Authors:  Valeriya Lyssenko; Cecilia L F Nagorny; Michael R Erdos; Nils Wierup; Anna Jonsson; Peter Spégel; Marco Bugliani; Richa Saxena; Malin Fex; Nicolo Pulizzi; Bo Isomaa; Tiinamaija Tuomi; Peter Nilsson; Johanna Kuusisto; Jaakko Tuomilehto; Michael Boehnke; David Altshuler; Frank Sundler; Johan G Eriksson; Anne U Jackson; Markku Laakso; Piero Marchetti; Richard M Watanabe; Hindrik Mulder; Leif Groop
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

10.  A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Authors:  Nabila Bouatia-Naji; Amélie Bonnefond; Christine Cavalcanti-Proença; Thomas Sparsø; Johan Holmkvist; Marion Marchand; Jérôme Delplanque; Stéphane Lobbens; Ghislain Rocheleau; Emmanuelle Durand; Franck De Graeve; Jean-Claude Chèvre; Knut Borch-Johnsen; Anna-Liisa Hartikainen; Aimo Ruokonen; Jean Tichet; Michel Marre; Jacques Weill; Barbara Heude; Maithé Tauber; Katleen Lemaire; Frans Schuit; Paul Elliott; Torben Jørgensen; Guillaume Charpentier; Samy Hadjadj; Stéphane Cauchi; Martine Vaxillaire; Robert Sladek; Sophie Visvikis-Siest; Beverley Balkau; Claire Lévy-Marchal; François Pattou; David Meyre; Alexandra I F Blakemore; Marjo-Riita Jarvelin; Andrew J Walley; Torben Hansen; Christian Dina; Oluf Pedersen; Philippe Froguel
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

View more
  116 in total

1.  Circadian Rhythm Sleep Disorders.

Authors:  Min Ju Kim; Jung Hie Lee; Jeanne F Duffy
Journal:  J Clin Outcomes Manag       Date:  2013-11-01

Review 2.  Circadian system, sleep and endocrinology.

Authors:  Christopher J Morris; Daniel Aeschbach; Frank A J L Scheer
Journal:  Mol Cell Endocrinol       Date:  2011-09-10       Impact factor: 4.102

3.  Temperament determination for melatonin: a bridge from Iranian traditional to modern sleep medicine.

Authors:  Mohammad B Minae; Seyedshahin Soltani; Mehdi Besharat; Foruzan Karimi; Esmaeil Nazem
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-12-31

4.  Evaluation of melatonin and AFMK levels in women with breast cancer.

Authors:  Tialfi Bergamin de Castro; Newton Antônio Bordin-Junior; Eduardo Alves de Almeida; Debora Aparecida Pires de Campos Zuccari
Journal:  Endocrine       Date:  2018-05-24       Impact factor: 3.633

5.  The effects of spectral tuning of evening ambient light on melatonin suppression, alertness and sleep.

Authors:  Shadab A Rahman; Melissa A St Hilaire; Steven W Lockley
Journal:  Physiol Behav       Date:  2017-05-01

6.  Are We Ready to Assess Circadian Phase at Home?

Authors:  Shadab A Rahman
Journal:  Sleep       Date:  2015-06-01       Impact factor: 5.849

7.  Sociodemographic characteristics and waking activities and their role in the timing and duration of sleep.

Authors:  Mathias Basner; Andrea M Spaeth; David F Dinges
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

8.  A study on the risk perception of light pollution and the process of social amplification of risk in Korea.

Authors:  Kyung Hee Kim; Jae Wook Choi; Eunil Lee; Yong Min Cho; Hyung Rae Ahn
Journal:  Environ Sci Pollut Res Int       Date:  2015-02-05       Impact factor: 4.223

Review 9.  Sex differences in circadian timing systems: implications for disease.

Authors:  Matthew Bailey; Rae Silver
Journal:  Front Neuroendocrinol       Date:  2013-11-25       Impact factor: 8.606

10.  Increased sensitivity of the circadian system to light in delayed sleep-wake phase disorder.

Authors:  Lauren A Watson; Andrew J K Phillips; Ihaia T Hosken; Elise M McGlashan; Clare Anderson; Leon C Lack; Steven W Lockley; Shantha M W Rajaratnam; Sean W Cain
Journal:  J Physiol       Date:  2018-10-25       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.